AI assistant
Sending…
RESMED INC — Director's Dealing 2022
Jan 20, 2022
30071_dirs_2022-01-20_101e96d2-9a88-4b36-9026-bd6e7fee21c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-01-18
Reporting Person: Douglas Robert Andrew (President and COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-01-18 | ResMed Common Stock | M | 8000 | $58.24 | Acquired | 25175 | Direct |
| 2022-01-18 | ResMed Common Stock | S | 8000 | $247.80 | Disposed | 17175 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-01-18 | ResMed Common Stock Options | $58.24 | M | 8000 | Disposed | 2022-11-19 | ResMed Common Stock (8000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 234995 | Indirect |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan.
F2: Represents date options first became exercisable. Options vest 1/3 per year.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29